In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...

MemorialCare Medical Group has appointed four accomplished physicians as Medical Directors: Rachael Lopez, M.D., Medical Director of Obstetrics and Gynecology; Irina Sachelarie, M.D., Medical Director ...

In this video, Leo I. Gordon, MD, FACP, discusses highlights from a debate at Lymphoma, Leukemia & Myeloma Congress on the evolving treatment landscape for relapsed or refractory diffuse large B-cell ...

Working with the same tumor slices that pathologists use to diagnose and guide treatment of patients, however, Carstens can ...

Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...

Secura Bio, Inc. ( an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today announced a poster presentation highlighting extended follow up analyses examining ...

NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Willamette Valley Cancer Institute and Research Center (WVCI), a leader in ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology ...

NORTON, Va. (WJHL) — In a Hematology/Oncology practice, every day brings challenges and heart. November’s Nurse Of The Month, ...

(MOASC), announces the winner of the Warren Fong, MD Advocacy Award. Since its founding in 1990, MOASC has been dedicated to improving cancer care in Southern California through strong advocacy, ...

Standardized evaluation protocol improved transfer, ECSL outcomes, and re-transfer to discharge for pediatric hematologic oncology patients.